Replimune Group Inc share price logo

Replimune Group Inc Share Price

NASDAQ: REPL

Small Cap

$5.69

-0.04

(-0.70%)

Live

as on

Replimune Group Inc Stock Performance

as on September 15, 2025 at 8:38 pm IST

  • Day's Low

    Day's High

    $5.6
    $5.8
    downward going graph

    1.58%

    Downside

    1.93%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.68
    $17
    downward going graph

    52.90%

    Downside

    198.77%

    Upside

    downward going graph

Replimune Group Inc share price movements today

Previous Close
$5.73
Open
$5.72
Volume
996.6K
Day's Low - High
$5.6 - $5.8
52 Week Low - High
$2.68 - $17

Replimune Group Inc Historical Returns

1 Month Return
+ 3.06 %
3 Month Return
-41.41 %
1 Year Return
-48.52 %
3 Year Return
-67.05 %
5 Year Return
-76.05 %

Replimune Group Inc Stock Fundamentals & Key Indicators

Check Replimune Group Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$447.3M

EPS (TTM)

-2.8128

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-287.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

6123800.00%

Replimune Group Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Replimune Group Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$447.3M-76.05%NA0.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Replimune Group Inc Stock including INR - Dollar returns

The Replimune Group Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Replimune Group Inc investment value today

Current value as on today

₹56,108

Returns

₹43,892

(-43.89%)

Returns from Replimune Group Inc Stock

₹48,877 (-48.88%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Replimune Group Inc Stock

Based on 15 analysts

BUY

93.33%

Buy

6.67%

Hold

0.00%

Sell

Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Replimune Group Inc. Average target price of $4.86

Replimune Group Inc Share Price Target

Get share price movements and forecasts by analysts on Replimune Group Inc.

What analysts predicted

-17.08%DOWNSIDE

Target Price

$4.86

Current Price

$5.69

Analyzed by

15 Analysts

Target

$4.86

Replimune Group Inc target price $4.86, a slight downside of -17.08% compared to current price of $5.69. According to 15 analysts rating.

Replimune Group Inc Stock's Interest Amongst Investors

Search interest for Replimune Group Inc Stock has decreased by -91% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-91% versus previous 30 day period

Replimune Group Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
4
-
-
-
1
-
Gross Profit
0
0
0
0
3
0
0
-1
0
-1
Operating Income
-52
-55
-63
-56
-58
-57
-58
-66
-79
-90
EBITDA
-47
-47
-62
-55
-57
-51
-50
-63
-71
-83
Interest Expense
1
1
1
1
1
1
1
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-48
-49
-60
-50
-55
-53
-53
-65
-74
-86
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-49
-49
-60
-51
-55
-53
-53
-66
-74
-86
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-1362.57%
0.00%
0.00%
0.00%
-5036.01%
0.00%

Replimune Group Inc Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-1
-4
-4
-2
-2
-3
Operating Income
-9
-19
-30
-56
-79
-118
-177
-234
-261
EBITDA
-8
-16
-28
-52
-76
-114
-170
-230
-261
Interest Expense
-
-
-
1
3
2
4
6
7
Depreciation
-
0
0
0
1
2
2
2
3
Income Before Tax
-7
-19
-30
-52
-80
-118
-173
-215
-246
Income Tax Expense
0
-2
0
1
2
1
0
0
0
Net Income
-7
-19
-30
-52
-80
-118
-174
-215
-247
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Replimune Group Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-49
-60
-51
-55
-53
-53
-66
-74
-86
Operating Cash Flow
-48
-43
-47
-46
-49
-38
-50
-53
-77
Investing Cash Flow
7
12
53
23
29
0
-46
-7
65
Financing Cash Flow
1
0
14
0
96
0
155
0
0
Change in Cash
-40
-30
21
-23
77
-38
58
-61
-13

Replimune Group Inc Annual Cash Flow

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
-19
-30
-52
-80
-118
-174
-215
-247
Operating Cash Flow
-16
-25
-60
-61
-82
-128
-185
-192
Investing Cash Flow
-44
-65
-5
-188
-1
-142
97
-23
Financing Cash Flow
54
101
100
372
6
311
16
252
Change in Cash
-3
9
34
123
-76
40
-72
36

Global Institutional Holdings in Replimune Group Inc

Funds
Holdings
Baker Bros Advisors LP
14.2%
T. Rowe Price Associates, Inc.
13.95%
BlackRock Inc
7.79%
Redmile Group, LLC
6.3%
FCPM III SERVICES BV
5.02%

Insights on Replimune Group Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 1.73 Cr → 2.49 Cr (in ₹), with an average increase of 30.5% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 31.32% to 31.34% in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 190.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, One 97 Communications Ltd has given 78.7% return, outperforming this stock by 105.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.55% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Firstsource Solutions Ltd has given 225.9% return, outperforming this stock by 236.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 124.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, REPL stock has moved down by -4.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, REPL stock has moved down by -5.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 37.13 Cr → 20.08 Cr (in ₹), with an average decrease of 45.9% per quarter

About Replimune Group Inc

replimune group, inc., a biotechnology company, develops oncolytic immune-gene therapies to treat cancer. it uses its proprietary immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. the company's lead product candidate is rp1, a selectively replicating version of herpes simplex virus 1, which is in phase i/ii clinical trials for a range of solid tumors; and that is in phase ii clinical trials for patients with cutaneous squamous cell carcinoma. it is also developing rp2, which is in phase i clinical trials for an anti-ctla-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by ctla-4; and rp3 to express immune-activating proteins that stimulate t cells. replimune group, inc. was founded in 2015 and is headquartered in woburn, massachusetts.
OrganisationReplimune Group Inc
Headquarters500 Unicorn Park Drive, Woburn, MA, United States, 01801
IndustryHealth Technology
CEODr. Sushil Patel Ph.D.
E-voting on sharesClick here to vote

Key Management of Replimune Group Inc

Name

Title

Mr. Camilo Garcia M.A., M.B.A.

Chief Human Resource Officer

Mr. Christopher Sarchi

Chief Commercial Officer

Mr. Paul Bullock

Chief Manufacturing Officer & Framingham Site Head

Dr. Sushil Patel Ph.D.

CEO & Director

Ms. Emily Luisa Hill

Chief Financial Officer

Dr. Konstantinos Xynos M.B.A., M.D., Ph.D.

Chief Medical Officer

Mr. Philip Astley-Sparke F.S.A.

Executive Chairman

Mr. Andrew Schwendenman

Chief Accounting Officer & Treasurer

Mr. Shawn Glidden J.D.

Senior VP & General Counsel

Ms. Nina Aragam

Senior Vice President of Portfolio Strategy & Program Management

FAQs

What is Replimune Group Inc share price today?

Replimune Group Inc share price today is $5.69 as on . Replimune Group Inc share today touched a day high of $5.8 and a low of $5.6.

What is the 52 week high and 52 week low for Replimune Group Inc share?

Replimune Group Inc share touched a 52 week high of $17 on and a 52 week low of $2.68 on . Replimune Group Inc stock price today i.e. is trending at $5.69,which is 66.53% down from its 52 week high and 112.31% up from its 52 week low.

What is Replimune Group Inc's market capitalisation today?

Replimune Group Inc market capitalisation is $0.00T as on .

How to invest in Replimune Group Inc Stock (REPL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Replimune Group Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Replimune Group Inc Shares that will get you 0.2636 shares as per Replimune Group Inc share price of $5.69 per share as on September 15, 2025 at 8:38 pm IST.

What is the minimum amount required to buy Replimune Group Inc Stock (REPL) from India?

Indian investors can start investing in Replimune Group Inc (REPL) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Replimune Group Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Replimune Group Inc share’s latest price of $5.69 as on September 15, 2025 at 8:38 pm IST, you will get 1.7575 shares of Replimune Group Inc. Learn more about fractional shares .

What are the returns that Replimune Group Inc has given to Indian investors in the last 5 years?

Replimune Group Inc stock has given -76.05% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?